Nadine Hein

2.3k total citations
36 papers, 1.1k citations indexed

About

Nadine Hein is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Nadine Hein has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Nadine Hein's work include RNA modifications and cancer (15 papers), Genomics and Chromatin Dynamics (8 papers) and Ubiquitin and proteasome pathways (7 papers). Nadine Hein is often cited by papers focused on RNA modifications and cancer (15 papers), Genomics and Chromatin Dynamics (8 papers) and Ubiquitin and proteasome pathways (7 papers). Nadine Hein collaborates with scholars based in Australia, United States and United Kingdom. Nadine Hein's co-authors include Ross D. Hannan, Katherine M. Hannan, Elaine Sanij, Amee J. George, Richard B. Pearson, Gretchen Poortinga, Grant A. McArthur, Leo Eberl, Beate Fehlhaber and Birgit Brenneke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Nadine Hein

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadine Hein Australia 14 849 278 148 115 59 36 1.1k
Li‐Jung Juan Taiwan 18 1.1k 1.3× 268 1.0× 215 1.5× 182 1.6× 169 2.9× 20 1.4k
Tuhina Mazumdar United States 17 398 0.5× 232 0.8× 146 1.0× 106 0.9× 143 2.4× 32 785
Claudia M. Espitia United States 17 646 0.8× 270 1.0× 404 2.7× 111 1.0× 105 1.8× 39 1.1k
Francesca Mattiroli Netherlands 16 1.7k 2.0× 399 1.4× 100 0.7× 123 1.1× 81 1.4× 26 1.8k
Leyma P. De Haro United States 7 1.3k 1.5× 379 1.4× 58 0.4× 235 2.0× 38 0.6× 10 1.5k
May Ann Lee Singapore 15 595 0.7× 239 0.9× 85 0.6× 54 0.5× 40 0.7× 23 842
Deborah Silvera United States 11 941 1.1× 227 0.8× 91 0.6× 179 1.6× 105 1.8× 14 1.3k
Xiaoyan Lou China 15 431 0.5× 376 1.4× 109 0.7× 189 1.6× 105 1.8× 29 828
Yan Coulombe Canada 24 1.4k 1.6× 409 1.5× 58 0.4× 220 1.9× 68 1.2× 39 1.6k
Ding Ma China 17 557 0.7× 198 0.7× 82 0.6× 166 1.4× 151 2.6× 33 915

Countries citing papers authored by Nadine Hein

Since Specialization
Citations

This map shows the geographic impact of Nadine Hein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadine Hein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadine Hein more than expected).

Fields of papers citing papers by Nadine Hein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadine Hein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadine Hein. The network helps show where Nadine Hein may publish in the future.

Co-authorship network of co-authors of Nadine Hein

This figure shows the co-authorship network connecting the top 25 collaborators of Nadine Hein. A scholar is included among the top collaborators of Nadine Hein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadine Hein. Nadine Hein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanchi, Madhu M., et al.. (2024). Biochemical-free enrichment or depletion of RNA classes in real-time during direct RNA sequencing with RISER. Nature Communications. 15(1). 4422–4422. 3 indexed citations
2.
Maclachlan, Kylee, Jian Kang, Andrew Cuddihy, et al.. (2024). Targeting the ribosome to treat multiple myeloma. SHILAP Revista de lepidopterología. 32(1). 200771–200771. 6 indexed citations
3.
Ferreira, Rita, Katherine M. Hannan, Kostya I. Panov, et al.. (2024). Abstract PR004: Second generation RNA Polymerase I inhibitor PMR-116 targets ribsomal RNA synthesis to potently treat a broad spectrum of malignancies. Molecular Cancer Therapeutics. 23(11_Supplement). PR004–PR004. 1 indexed citations
4.
Cameron, Donald P., Denis Drygin, Gretchen Poortinga, et al.. (2024). CX-5461 Preferentially Induces Top2α-Dependent DNA Breaks at Ribosomal DNA Loci. Biomedicines. 12(7). 1514–1514. 4 indexed citations
5.
Ferreira, Rita & Nadine Hein. (2023). Purification of Mouse Embryonic Fibroblasts (MEFs). Current Protocols. 3(11). e921–e921. 5 indexed citations
6.
Kang, Chang Won, Katherine M. Hannan, Anneke C. Blackburn, et al.. (2022). The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma. Investigational New Drugs. 40(3). 529–536. 4 indexed citations
7.
Gardiner, Michael G., Priscilla Soo, Megan Pavy, et al.. (2021). The Synthesis and Biological Evaluation of Some C-9 and C-10 Substituted Derivatives of the RNA Polymerase I Transcription Inhibitor CX-5461. Australian Journal of Chemistry. 74(7). 540–556. 1 indexed citations
8.
Khot, Amit, Natalie Brajanovski, Donald P. Cameron, et al.. (2019). First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study. Cancer Discovery. 9(8). 1036–1049. 132 indexed citations
9.
Diesch, Jeannine, Megan J. Bywater, Elaine Sanij, et al.. (2019). Changes in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformation. Communications Biology. 2(1). 39–39. 32 indexed citations
10.
Soo, Priscilla, M. Evers, Nadine Hein, et al.. (2018). High-Content Imaging Approaches to Quantitate Stress-Induced Changes in Nucleolar Morphology. Assay and Drug Development Technologies. 16(6). 320–332. 6 indexed citations
11.
Maclachlan, Kylee, Andrew Cuddihy, Nadine Hein, et al.. (2017). Novel Combination Therapies with the RNA Polymerase I Inhibitor CX-5461 Significantly Improve Efficacy in Multiple Myeloma. Blood. 130. 1805. 3 indexed citations
12.
Khot, Amit, Natalie Brajanovski, Donald P. Cameron, et al.. (2017). RNA Polymerase 1 Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Malignancies: Results of a Phase I First in Human Study. Blood. 130. 3835–3835. 2 indexed citations
13.
Quin, Jaclyn, Keefe T. Chan, Jennifer R. Devlin, et al.. (2016). Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling. Oncotarget. 7(31). 49800–49818. 79 indexed citations
14.
Devlin, Jennifer R., Katherine M. Hannan, Nadine Hein, et al.. (2015). Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma. Cancer Discovery. 6(1). 59–70. 91 indexed citations
15.
Khot, Amit, Natalie Brajanovski, Donald P. Cameron, et al.. (2015). A Phase 1, Open-Label, Dose Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of a first in class Pol1 inhibitor (CX-5461) in Patients with Advanced Haematologic Malignancies (HM). Clinical Lymphoma Myeloma & Leukemia. 15. e280–e281. 2 indexed citations
16.
Sanij, Elaine, Jeannine Diesch, Gretchen Poortinga, et al.. (2014). A novel role for the Pol I transcription factor UBTF in maintaining genome stability through the regulation of highly transcribed Pol II genes. Genome Research. 25(2). 201–212. 45 indexed citations
17.
Pearson, Richard B., Jennifer R. Devlin, Katherine M. Hannan, et al.. (2014). Abstract 2735: Multi-point targeting of the synthetic lethal interactions between Myc, ribosome biogenesis and ribosome function cooperates to treat B-cell lymphoma. Cancer Research. 74(19_Supplement). 2735–2735. 1 indexed citations
18.
Hein, Nadine, Katherine M. Hannan, Amee J. George, Elaine Sanij, & Ross D. Hannan. (2013). The nucleolus: an emerging target for cancer therapy. Trends in Molecular Medicine. 19(11). 643–654. 194 indexed citations
19.
20.
Jiang, Kan, Nadine Hein, Kaitlyn M. Eckert, Juliane Lüscher‐Firzlaff, & Bernhard Lüscher. (2008). Regulation of the MAD1 promoter by G-CSF. Nucleic Acids Research. 36(5). 1517–1531. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li‐Jung Juan Breakdown of academic impact, for papers by Tuhina Mazumdar Breakdown of academic impact, for papers by Claudia M. Espitia Breakdown of academic impact, for papers by Francesca Mattiroli Breakdown of academic impact, for papers by Leyma P. De Haro Breakdown of academic impact, for papers by May Ann Lee Breakdown of academic impact, for papers by Deborah Silvera Breakdown of academic impact, for papers by Xiaoyan Lou Breakdown of academic impact, for papers by Yan Coulombe Breakdown of academic impact, for papers by Ding Ma
Rankless by CCL
2026